Approved for To treat adult and pediatric (12 years and older) solid tumor indications approved for the intravenous formulation of pembrolizumab. 12.1 Mechanism of Action Binding of the PD-1 ligands, PD-L1 and PD-L2, to the PD-1 receptor found on T cells, inhibits T cell proliferation and cytokine production. Upregulation of PD-1 ligands… Side effects, costs, interactions, manufacturer, and…
Loading full data from Know Your Drugs Institute…